Dexcom (DXCM) Acquisitions (2021 - 2022)
Dexcom's (DXCM) quarterly Acquisitions came in at $700000.0 in Q3 2022, down 97.78% year-over-year from $31.6 million in Q3 2021, and down 78.12% quarter-over-quarter from $3.2 million in Q1 2022.
Powered by 
Analysis
Dexcom (DXCM) Acquisitions (2021 - 2022) Analysis & Trends
Dexcom (DXCM) has reported Acquisitions for 2 consecutive years, with $700000.0 the latest figure, recorded in Q3 2022.
- On a quarterly basis, Acquisitions fell 97.78% year-over-year to $700000.0 in Q3 2022; TTM through Jun 2023 was $700000.0, a 97.9% decrease from a year earlier, with the FY2022 full-year figure at $3.9 million, down 87.09% from the prior year.
- Acquisitions was $700000.0 for Q3 2022 at Dexcom, down from $3.2 million in the prior quarter.
- Over five years, Acquisitions peaked at $31.6 million in Q3 2021 and troughed at -$1.4 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.16 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 437.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | -1.40 Mn |
| Sep 30, 2021 | 31.60 Mn |